Computational Repurposing of Janus Kinase Inhibitors as Potential Therapeutic Candidates for Alzheimer’s Disease
Background and Objectives: Alzheimer’s disease (AD) is the most common neurodegenerative disorder, and current therapies provide only limited symptomatic relief without effectively slowing its progression. Increasing evidence suggests that aberrant activation of the Janus kinase/signal transducer and activator of trans...